| Primary |
| Product Used For Unknown Indication |
45.9% |
| Rheumatoid Arthritis |
12.7% |
| Crohn's Disease |
11.0% |
| Psoriasis |
5.9% |
| Psoriatic Arthropathy |
3.7% |
| Hypertension |
3.1% |
| Pain |
2.5% |
| Vitamin Supplementation |
2.1% |
| Depression |
1.6% |
| Ankylosing Spondylitis |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Blood Cholesterol Increased |
1.2% |
| Diabetes Mellitus |
1.1% |
| Anxiety |
1.1% |
| Colitis Ulcerative |
1.0% |
| Insomnia |
1.0% |
| Blood Pressure |
0.9% |
| Hypersensitivity |
0.9% |
| Asthma |
0.8% |
| Hypothyroidism |
0.7% |
|
| Injection Site Pain |
24.8% |
| Psoriasis |
6.5% |
| Wrong Technique In Drug Usage Process |
6.5% |
| Drug Ineffective |
5.9% |
| Sinusitis |
5.5% |
| Pain |
5.2% |
| Nasopharyngitis |
4.5% |
| Injection Site Swelling |
4.0% |
| Injection Site Bruising |
3.9% |
| Rash |
3.8% |
| Vomiting |
3.5% |
| Nausea |
3.4% |
| Injection Site Haemorrhage |
3.3% |
| Pain In Extremity |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Headache |
3.1% |
| Injection Site Pruritus |
2.7% |
| Pyrexia |
2.5% |
| Fatigue |
2.4% |
| Off Label Use |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
40.3% |
| Crohn's Disease |
14.5% |
| Rheumatoid Arthritis |
8.8% |
| Psoriasis |
7.3% |
| Psoriatic Arthropathy |
4.1% |
| Hypertension |
3.8% |
| Pain |
3.1% |
| Vitamin Supplementation |
2.4% |
| Depression |
2.2% |
| Colitis Ulcerative |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Blood Cholesterol Increased |
1.4% |
| Anxiety |
1.3% |
| Ankylosing Spondylitis |
1.3% |
| Insomnia |
1.2% |
| Hypersensitivity |
1.1% |
| Diabetes Mellitus |
1.1% |
| Asthma |
1.0% |
| Hypothyroidism |
0.9% |
| Blood Pressure |
0.8% |
|
| Injection Site Pain |
20.8% |
| Psoriasis |
8.2% |
| Vomiting |
6.8% |
| Sinusitis |
5.9% |
| Pain |
5.5% |
| Rheumatoid Arthritis |
5.4% |
| Wrong Technique In Drug Usage Process |
5.4% |
| Off Label Use |
5.0% |
| Drug Ineffective |
4.6% |
| Nausea |
4.0% |
| Injection Site Bruising |
3.5% |
| Nasopharyngitis |
3.5% |
| Weight Decreased |
3.1% |
| Headache |
2.9% |
| Weight Increased |
2.9% |
| Injection Site Swelling |
2.7% |
| Pain In Extremity |
2.7% |
| Pyrexia |
2.5% |
| Urinary Tract Infection |
2.4% |
| Rash |
2.3% |
|
| Concomitant |
| Migraine |
17.4% |
| Colitis |
8.7% |
| Drug Use For Unknown Indication |
8.7% |
| Headache |
8.7% |
| Itching |
8.7% |
| Pain |
8.7% |
| Plaque Psoriasis |
8.7% |
| Psoriatic Arthropathy |
8.7% |
| Staphylococcal Infection |
8.7% |
| Swelling |
8.7% |
| Colitis Ulcerative |
4.3% |
|
| Urticaria |
66.7% |
| Rash Papular |
33.3% |
|
| Interacting |
| Product Used For Unknown Indication |
75.0% |
| Psoriatic Arthropathy |
25.0% |
|
|
